Dopaminergic antiparkinsonism agents

Neupro 8 mg/24 hours transdermal system Images

Generic Name: rotigotine

This medication has been identified as Neupro 8 mg/24 hours transdermal system. It is supplied by UCB, Inc.

Neupro is used in the treatment of Restless Legs Syndrome; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Neupro 8 mg/24 hours transdermal system is not a controlled substance under the Controlled Substances Act (CSA).

Images

Neupro skin patches (Rotigotine (transdermal) [ roe-tig-oh-teen ])-medicine-8 mg/24 hours transdermal system
Neupro skin patches (Rotigotine (transdermal) [ roe-tig-oh-teen ])-medicine-8 mg/24 hours transdermal system

Neupro skin patches
Generic Name: rotigotine (transdermal) [ roe-tig-oh-teen ]
Imprint: medicine
Strength: 8 mg/24 hours transdermal system
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Dopaminergic antiparkinsonism agents
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 50474-0806
Inactive Ingredients:
Latest News
Related Drugs